From concerning statistics on global health outcomes to new insights on AI and RWD, explore the top pharma news from July ...

CHENNAI: Gilead Sciences has achieved another milestone in its efforts to bring in a preventive drug to curb the still ...

WHO endorses biannual injectable Lenacapavir for HIV prevention. This long-acting PrEP offers hope for high-risk groups and ...

Fiji is facing a sharp rise in HIV cases, with experts warning that treatment alone will not stop the epidemic. UNAIDS ...

Researchers found that lenacapavir reduced almost 100% reduction new HIV infections among participants who received it as a ...

New WHO guidelines endorse long-acting injectable lenacapavir for HIV prevention, Medicines Patent Pool expands licence for ...

The program known as PEPFAR is one of the most effective and popular U.S. foreign aid projects in history, and the government says it has saved the lives of over 25 million people around the ...

Rahway, New Jersey Wednesday, July 16, 2025, 17:30 Hrs [IST] ...

It has played an important role in testing for and tracking HIV infections. HIV/AIDS has no cure, and it has killed over 40 million people globally over the years.

The country isn’t getting extra money from the Global Fund to Fight Aids, TB and Malaria; it has to use cash from a grant it ...

Zimbabwe has earned widespread international praise for its achievements in the fight against HIV, with the latest UNAIDS Global AIDS Update 2025 placing the ...

Rahway: Merck, known as MSD outside of the United States and Canada, has announced the initiation of the EXPrESSIVE Phase 3 clinical trials, evaluating the safety and efficacy of MK-8527, ...